athenahealth, Inc., together with its subsidiaries, provides network-based medical record, revenue cycle, patient engagement, care coordination, and population health services for medical groups and health systems. It offers athenaCollector, a network-enabled billing and practice management solution; athenaClinicals, an electronic health record for managing patient's clinical documentation; athenaCommunicator, an engagement and communication solution that provides an automated communication service between patients and provider practices for interactions outside the exam room; and athenaCoordinator for order transmission and care coordination services. The company also provides athenahealth Population Health, a cloud-based population health service; and Epocrates services that include clinical information and decision support services in the areas of drug and disease information, medical calculator and tools, clinical guidelines, clinical messaging, and market research. In addition, it offers athenahealth Health Plan data exchange facilitates to exchange the data between providers and health plans for the healthcare operations of clients; athenaOne Analytics that includes an analytics and dashboard application, as well as provides visibility into the financial and operational health of an organization; and pre-certification processing and referral processing services. The company serves healthcare providers, medical groups, and health systems through its direct sales force and channel partners in the United States and internationally. athenahealth, Inc. was formerly known as athenahealth.com, Inc. and changed its name to athenahealth, Inc. in November 2000. The company was founded in 1997 and is headquartered in Watertown, Massachusetts.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Business services, not elsewhere classified
Sub-IndustryHealth Care Technology
SectorMedical
Current SymbolNASDAQ:ATHN
Previous Symbol
CUSIP04685W10
Phone617-402-1000
Debt
Debt-to-Equity Ratio0.22
Current Ratio2.74
Quick Ratio2.62
Price-To-Earnings
Trailing P/E Ratio83.80
Forward P/E Ratio40.99
P/E Growth2.32
Sales & Book Value
Annual Sales$1.22 billion
Price / Sales4.38
Cash Flow$5.2797 per share
Price / Cash24.92
Book Value$26.30 per share
Price / Book5.00
Profitability
EPS (Most Recent Fiscal Year)$1.57
Net Income$53.10 million
Net Margins9.57%
Return on Equity15.35%
Return on Assets10.04%
Miscellaneous
Employees5,156
Outstanding Shares40,610,000
Market Cap$5.34 billion
OptionableOptionable
athenahealth (NASDAQ:ATHN) Frequently Asked Questions
What is athenahealth's stock symbol?
athenahealth trades on the NASDAQ under the ticker symbol "ATHN."
How were athenahealth's earnings last quarter?
athenahealth, Inc (NASDAQ:ATHN) posted its quarterly earnings data on Friday, November, 9th. The health services provider reported $0.81 EPS for the quarter, topping the Zacks' consensus estimate of $0.71 by $0.10. The health services provider had revenue of $331.40 million for the quarter, compared to analyst estimates of $336.98 million. athenahealth had a return on equity of 15.35% and a net margin of 9.57%. The firm's quarterly revenue was up 8.8% on a year-over-year basis. During the same period in the previous year, the firm earned $0.56 earnings per share. View athenahealth's Earnings History.
When is athenahealth's next earnings date?
What guidance has athenahealth issued on next quarter's earnings?
athenahealth updated its FY 2018 earnings guidance on Friday, November, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.335-1.365 billion, compared to the consensus revenue estimate of $1.35 billion.
What price target have analysts set for ATHN?
20 Wall Street analysts have issued 1 year price targets for athenahealth's shares. Their forecasts range from $135.00 to $179.00. On average, they anticipate athenahealth's share price to reach $149.0526 in the next twelve months. This suggests a possible upside of 13.3% from the stock's current price. View Analyst Price Targets for athenahealth.
What is the consensus analysts' recommendation for athenahealth?
20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for athenahealth in the last year. There are currently 17 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for athenahealth.
What are Wall Street analysts saying about athenahealth stock?
Here are some recent quotes from research analysts about athenahealth stock:
- 1. Cantor Fitzgerald analysts commented, "Growth at ATHN appears to be slowing. athena’s top-line growth has certainly decelerated, as evidenced by the decline in bookings for 1Q18. Bookings picked up in 2Q18 but it remains to be seen if that is sustainable. ATHN’s KLAS Research scores for Collector and Clinicals have held up well. It remains to be seen if the company’s efforts to expand into the hospital market and population health will pay dividends. Nonetheless, the magnitude of the margin expansion in 1H18 demonstrates the inherent leverage in the recurring revenue model, in our view. We reiterate our Neutral rating on the shares." (9/18/2018)
- 2. Canaccord Genuity analysts commented, "We remain neutral on the stock until we get a better understanding of the restructuring initiatives, financial predictability, and the go-forward growth strategy. Pre-call takeaways: Upside to revenue, with significant bottom-line beat. Rev. of $329.2M (+14.2%) beat our est. $324.8M and cons. $320.0M, and came in at the high end of implied guidance range $309-$329M. Beats on adjusted gross margin and all expense line items enabled the company to post non-GAAP op. inc. of $77.6M (+82.6%), far surpassing us and cons. both near ~$45M and implied guidance of $38-53M. Adj-EPS of $1.11 also beat our est. $0.65 and cons. $0.63." (2/1/2018)
Has athenahealth been receiving favorable news coverage?
Media stories about ATHN stock have trended somewhat positive on Friday, according to InfoTrie Sentiment. The research group ranks the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. athenahealth earned a coverage optimism score of 0.7 on InfoTrie's scale. They also assigned news stories about the health services provider a news buzz of 5.0 out of 10, indicating that recent news coverage is somewhat likely to have an impact on the stock's share price in the immediate future.
Who are some of athenahealth's key competitors?
Some companies that are related to athenahealth include Pinduoduo (PDD), FleetCor Technologies (FLT), Global Payments (GPN), First Data (FDC), Total System Services (TSS), Mercadolibre (MELI), Ctrip.Com International (CTRP), Msci (MSCI), CoStar Group (CSGP), Broadridge Financial Solutions (BR), Akamai Technologies (AKAM), Alliance Data Systems (ADS), Nielsen (NLSN), The Western Union (WU) and GrubHub (GRUB).
Who are athenahealth's key executives?
athenahealth's management team includes the folowing people:
- Mr. Prakash Khot, Exec. VP & CTO (Age 48)
- Mr. Daniel P. Haley, Sr. VP and Chief Legal & Admin. Officer (Age 45)
- Mr. Jonathan Porter, Sr. VP & Chief Product Officer (Age 43)
- Mr. Jeffrey R. Immelt, Exec. Chairman of Directors (Age 61)
- Mr. Marc A. Levine, Exec. VP, CFO, Chief Accounting Officer & Treasurer (Age 58)
Who are athenahealth's major shareholders?
athenahealth's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Janus Henderson Group PLC (11.63%), BlackRock Inc. (4.29%), Credit Suisse AG (4.00%), FMR LLC (2.75%), Riverbridge Partners LLC (2.19%) and MERIAN GLOBAL INVESTORS UK Ltd (1.96%). Company insiders that own athenahealth stock include Amy Abernethy, Bradford Kyle Armbrester, Brandon H Hull, Daniel P Haley, David Eric Robinson, Ed Park, Jeffrey R Immelt, John A Kane, Jonathan Bush, Jonathan D Porter, Karl Stubelis and Timothy John O'brien. View Institutional Ownership Trends for athenahealth.
Which major investors are selling athenahealth stock?
ATHN stock was sold by a variety of institutional investors in the last quarter, including Capital Research Global Investors, FMR LLC, Wells Fargo & Company MN, Bank of New York Mellon Corp, Kornitzer Capital Management Inc. KS, Janus Henderson Group PLC, Macquarie Group Ltd. and Capital Fund Management S.A.. Company insiders that have sold athenahealth company stock in the last year include Amy Abernethy, Bradford Kyle Armbrester, Brandon H Hull, Daniel P Haley, David Eric Robinson, Jonathan Bush, Jonathan D Porter and Timothy John O'brien. View Insider Buying and Selling for athenahealth.
Which major investors are buying athenahealth stock?
ATHN stock was purchased by a variety of institutional investors in the last quarter, including MERIAN GLOBAL INVESTORS UK Ltd, State of New Jersey Common Pension Fund D, Credit Suisse AG, United Services Automobile Association, Canada Pension Plan Investment Board, Man Group plc, DLD Asset Management LP and Alpine Associates Management Inc.. View Insider Buying and Selling for athenahealth.
How do I buy shares of athenahealth?
Shares of ATHN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is athenahealth's stock price today?
One share of ATHN stock can currently be purchased for approximately $131.51.
How big of a company is athenahealth?
athenahealth has a market capitalization of $5.34 billion and generates $1.22 billion in revenue each year. The health services provider earns $53.10 million in net income (profit) each year or $1.57 on an earnings per share basis. athenahealth employs 5,156 workers across the globe.
What is athenahealth's official website?
How can I contact athenahealth?
athenahealth's mailing address is 311 ARSENAL STREET, WATERTOWN MA, 02472. The health services provider can be reached via phone at 617-402-1000 or via email at [email protected]
MarketBeat Community Rating for athenahealth (NASDAQ ATHN)
MarketBeat's community ratings are surveys of what our community members think about athenahealth and other stocks. Vote "Outperform" if you believe ATHN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ATHN will underperform the S&P 500 over the long term. You may vote once every thirty days.
